Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

Post by Wakojakoon Jul 18, 2015 10:38pm

479 Views

Post# 23938124

Great investment

Valued at 1.30 - 1.36$ for .78 ...... Just took a position this will be a takeover target 100% hopefully sooner than later . Already have been several offers from 1.40 - 2$ + , no brainer here order backlog 393 million as of March ...

Heres all need to read for your DD in one spot

https://m.seekingalpha.com/article/3083046-the-napec-turnaround-mispriced-security-offers-a-lot-of-upside

your welcome

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload